Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Historical Holders from Q3 2016 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
ADPT on Nasdaq
Shares outstanding
151,865,218
Price per share
$16.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
145,445,972
Total reported value
$2,175,466,292
% of total 13F portfolios
0%
Share change
-2,761,664
Value change
-$14,778,502
Number of holders
268
Price from insider filings
$16.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.7% $83,304,289 9,940,846 BlackRock, Inc. 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc. 4.6% $57,261,688 6,833,137 Sumitomo Mitsui Trust Group, Inc. 31 Dec 2024
Nikko Asset Management Americas, Inc. 4.6% $57,261,688 6,833,137 Nikko Asset Management Americas, Inc. 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 4.3% $52,732,273 6,292,634 Millennium Management LLC 31 Dec 2024
Rubric Capital Management LP 4.1% $58,126,109 6,256,847 Rubric Capital Management LP 30 Jun 2025
ARK Investment Management LLC 2.9% -27% $40,863,635 -$15,506,311 4,398,669 -28% ARK Investment Management LLC 31 May 2025
As of 30 Sep 2025, Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 268 institutional shareholders filing 13F forms. They hold 145,445,972 shares. of 151,865,218 outstanding shares (96%) .

Top 25 institutional shareholders own 71% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VIKING GLOBAL INVESTORS LP 20% 29,993,708 0% 1.2% $448,705,872
BlackRock, Inc. 8.8% 13,357,977 -2.3% 0% $199,835,344
VANGUARD GROUP INC 7.4% 11,275,169 -0.04% 0% $168,676,528
AMERIPRISE FINANCIAL INC 3.9% 5,971,706 +84% 0.02% $89,336,731
Sumitomo Mitsui Trust Group, Inc. 2.4% 3,650,646 -15% 0.03% $54,613,664
Amova Asset Management Americas, Inc. 2.4% 3,650,646 -15% 0.53% $54,650,171
GEODE CAPITAL MANAGEMENT, LLC 2.2% 3,401,030 +5.8% 0% $50,885,690
ARK Investment Management LLC 2.1% 3,165,636 -21% 0.28% $47,357,912
Aristotle Atlantic Partners, LLC 2.1% 3,126,719 +8.6% 1.4% $46,775,716
STATE STREET CORP 2% 3,079,282 +1.7% 0% $46,066,059
Driehaus Capital Management LLC 2% 3,019,940 +25% 0.32% $45,178,302
FRED ALGER MANAGEMENT, LLC 1.7% 2,514,234 +6.7% 0.15% $37,612,941
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.6% 2,441,402 +544% 0.02% $36,523,374
Blue Water Life Science Advisors, LP 1.4% 2,145,145 0% 29% $32,091,369
MACQUARIE GROUP LTD 1.4% 2,104,414 +219% 0.04% $31,482,000
GOLDMAN SACHS GROUP INC 1.2% 1,879,852 -2.5% 0% $28,122,586
Iron Triangle Partners LP 1.2% 1,820,915 +22% 3.9% $27,240,888
DEUTSCHE BANK AG\ 1.1% 1,713,139 +905% 0.01% $25,628,559
BANK OF AMERICA CORP /DE/ 1.1% 1,597,999 -14% 0% $23,906,066
DIMENSIONAL FUND ADVISORS LP 0.91% 1,386,363 -0.24% 0% $20,730,107
JENNISON ASSOCIATES LLC 0.86% 1,311,487 +1269% 0.01% $19,619,844
Voya Investment Management LLC 0.86% 1,304,609 -16% 0.02% $19,516,950
KENNEDY CAPITAL MANAGEMENT LLC 0.84% 1,273,646 -1.9% 0.42% $19,053,744
VICTORY CAPITAL MANAGEMENT INC 0.82% 1,246,573 -27% 0.01% $18,648,732
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.82% 1,239,625 -15% 0.01% $18,544,790

Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 273,359 $4,437,487 +$84,372 $16.24 11
2025 Q3 145,445,972 $2,175,466,292 -$14,778,502 $14.96 268
2025 Q2 148,178,882 $1,726,248,551 -$46,396,284 $11.65 240
2025 Q1 152,930,142 $1,136,092,939 +$68,698,964 $7.43 222
2024 Q4 143,279,887 $858,522,796 +$3,866,677 $6.00 204
2024 Q3 143,105,692 $732,467,911 -$27,674,384 $5.12 185
2024 Q2 148,655,164 $538,029,273 +$26,561,733 $3.62 174
2024 Q1 142,339,746 $456,277,783 -$10,561,768 $3.21 185
2023 Q4 268,773 $1,332,340 -$1,282,936 $4.90 4
2023 Q3 139,274,780 $759,067,292 +$15,537,871 $5.45 183
2023 Q2 135,867,468 $911,627,693 +$14,825,464 $6.71 204
2023 Q1 133,191,971 $1,173,602,347 +$16,706,318 $8.83 219
2022 Q4 131,865,060 $1,007,221,056 +$16,344,735 $7.64 211
2022 Q3 130,237,818 $926,050,737 -$29,685,679 $7.12 197
2022 Q2 123,551,443 $994,627,677 +$16,408,942 $8.09 189
2022 Q1 125,386,776 $1,739,009,638 -$39,536,455 $13.88 203
2021 Q4 123,408,753 $3,461,062,154 +$139,816,221 $28.06 205
2021 Q3 117,824,785 $4,002,581,930 -$423,355 $33.99 212
2021 Q2 117,392,344 $4,794,501,462 +$143,075,153 $40.86 225
2021 Q1 113,669,304 $4,576,107,601 -$120,106,781 $40.26 239
2020 Q4 113,936,424 $6,737,190,190 +$154,326,915 $59.13 241
2020 Q3 111,278,021 $5,408,061,056 +$508,490,697 $48.63 202
2020 Q2 99,919,228 $4,832,257,629 +$200,317,054 $48.38 187
2020 Q1 96,113,163 $2,669,688,515 +$277,820,131 $27.78 141
2019 Q4 85,969,227 $2,572,174,908 +$148,102,683 $29.92 126
2019 Q3 81,040,169 $2,492,288,624 +$38,865,286 $30.90 115
2019 Q2 78,227,891 $3,735,238,853 +$3,730,992,062 $48.30 109
2019 Q1 103,941 $4,247,000 $0 $40.86 1
2016 Q4 0 $0 -$10,117 $16.24 0
2016 Q3 235 $10,117 +$10,117 $43.05 1